Laird Norton Wetherby Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,081
| Closed | -$369K | – | 949 |
|
|
2022
Q1 | $369K | Buy |
5,081
+125
| +3% | +$9.08K | 0.02% | 626 |
|
|
2021
Q4 | $417K | Buy |
4,956
+204
| +4% | +$17.2K | 0.02% | 585 |
|
|
2021
Q3 | $429K | Sell |
4,752
-5
| -0.1% | -$451 | 0.03% | 549 |
|
|
2021
Q2 | $454K | Buy |
+4,757
| New | +$454K | 0.03% | 546 |
|
|
2021
Q1 | – | Sell |
-4,749
| Closed | -$657K | – | 857 |
|
|
2020
Q4 | $657K | Buy |
+4,749
| New | +$657K | 0.04% | 377 |
|